Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Enterprise Value: 5.005B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 5.005B |
| November 14, 2024 | 5.239B |
| November 13, 2024 | 5.251B |
| November 12, 2024 | 5.297B |
| November 11, 2024 | 5.538B |
| November 08, 2024 | 5.612B |
| November 07, 2024 | 5.517B |
| November 06, 2024 | 5.517B |
| November 05, 2024 | 5.362B |
| November 04, 2024 | 5.193B |
| November 01, 2024 | 5.171B |
| October 31, 2024 | 5.119B |
| October 30, 2024 | 5.232B |
| October 29, 2024 | 5.281B |
| October 28, 2024 | 5.406B |
| October 25, 2024 | 5.265B |
| October 24, 2024 | 5.473B |
| October 23, 2024 | 5.479B |
| October 22, 2024 | 6.103B |
| October 21, 2024 | 6.007B |
| October 18, 2024 | 6.186B |
| October 17, 2024 | 6.078B |
| October 16, 2024 | 6.266B |
| October 15, 2024 | 6.096B |
| October 14, 2024 | 6.158B |
| Date | Value |
|---|---|
| October 11, 2024 | 6.179B |
| October 10, 2024 | 6.097B |
| October 09, 2024 | 6.015B |
| October 08, 2024 | 6.095B |
| October 07, 2024 | 6.164B |
| October 04, 2024 | 6.274B |
| October 03, 2024 | 6.173B |
| October 02, 2024 | 6.177B |
| October 01, 2024 | 6.139B |
| September 30, 2024 | 6.088B |
| September 27, 2024 | 6.333B |
| September 26, 2024 | 6.471B |
| September 25, 2024 | 6.429B |
| September 24, 2024 | 6.488B |
| September 23, 2024 | 6.541B |
| September 20, 2024 | 6.961B |
| September 19, 2024 | 6.626B |
| September 18, 2024 | 6.582B |
| September 17, 2024 | 6.130B |
| September 16, 2024 | 6.610B |
| September 13, 2024 | 5.009B |
| September 12, 2024 | 4.635B |
| September 11, 2024 | 4.891B |
| September 10, 2024 | 5.011B |
| September 09, 2024 | 5.125B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
84.79M
Minimum
May 16 2022
6.961B
Maximum
Sep 20 2024
2.165B
Average
1.566B
Median
Nov 11 2022
Enterprise Value Benchmarks
| Viking Therapeutics Inc | 4.595B |
| Bristol-Myers Squibb Co | 155.74B |
| Replimune Group Inc | 352.42M |
| Moderna Inc | 7.314B |
| NovaBay Pharmaceuticals Inc | 2.764M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -84.34M |
| Total Expenses (Quarterly) | 76.33M |
| EPS Diluted (Quarterly) | -1.28 |
| Earnings Yield | -3.99% |